Citius Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cranford, NJ
CTXR chart
What traders are saying about $CTXR
Latest postsCitius Pharmaceuticals, Inc. news
- CTOR Stock Price, Quote & Chart
ChartMill ·
- Citius Oncology Reports Continued Institutional Demand and 120% Growth in Shipments of LYMPHIR® Units to U.S. Wholesalers During the Fiscal Fourth Quarter of 2026
Yahoo Finance ·
- Nasdaq gives Citius Oncology (NASDAQ: CTOR) more time to meet its $1 share-price rule.
Stock Titan ·
- Citius Pharmaceuticals, Inc. Estimates – BOATS:CTXR
TradingView ·
- Citius Pharmaceuticals to Participate in October 2026 Investor Conferences
Yahoo Finance ·
- Citius Pharmaceuticals to Participate in September 2026 Investor Conferences
Yahoo Finance ·
- Citius Pharmaceuticals, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Citius Oncology, Inc. Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri
Yahoo Finance ·
- Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment
Yahoo Finance ·
- Citius Oncology Reports Nationwide Deployment of LYMPHIR's Broadened Commercial Organization and Expanding Market Adoption
Yahoo Finance ·
- Citius Oncology Highlights Phase 1 Data in an Investigator-Initiated Study of LYMPHIR® (denileukin diftitox-cxdl) in Combination with Pembrolizumab in Recurrent or Refractory Gynecologic Malignancies
Yahoo Finance ·
Citius Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | – | – | -$32.5M | -$33.6M |
| Diluted EPS | $-3.38 | $-5.97 | $-5.57 | $-0.23 |
| Total assets (year end) | $140.4M | $120.7M | $97.4M | $111.7M |
| Cash and equivalents (year end) | $7.7M | $1.1M | $20.3M | $36.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Citius Pharmaceuticals, Inc.
- Ticker
- CTXR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cranford, NJ
- Incorporated in
- NV
- Fiscal year end
- September 30
- SEC CIK
- 1506251
- Former names
- Trail One, Inc., TrailOne, Inc.
Frequently asked questions
What exchange is Citius Pharmaceuticals, Inc. listed on?
Citius Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol CTXR.
What industry is Citius Pharmaceuticals, Inc. in?
Citius Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Citius Pharmaceuticals, Inc. headquartered?
Citius Pharmaceuticals, Inc.'s business address on file with the SEC is in Cranford, NJ.
When does Citius Pharmaceuticals, Inc.'s fiscal year end?
Citius Pharmaceuticals, Inc.'s fiscal year ends on September 30.
How much revenue did Citius Pharmaceuticals, Inc. report?
Citius Pharmaceuticals, Inc. reported $0 in revenue for calendar year 2013, according to its SEC filings.